For some, it's sweet charity. For others, it reflects the sad state of U.S. healthcare and the general economy, but for 37 women in rural Northern California, it was an opportunity to be screened for breast cancer.
For some, it's sweet charity. For others, it reflects the sad state of U.S. healthcare and the general economy, but for 37 women in rural Northern California, it was an opportunity to be screened for breast cancer. They were the lucky winners of free screening mammograms raffled off to mark National Breast Cancer Awareness Month.
The 5th annual drawing, on Oct. 29, was sponsored by the American Cancer Society, the Humboldt Community Breast Health Project, and seven area hospitals and radiology centers.
Mammograms were donated by the Mad River Community Hospital and North Bay Radiology in Arcata, St. Joseph Hospital and Humboldt Radiology Group in Eureka, Redwood Memorial Hospital and Sonoma Imaging in Fortuna, and Jerold Phelps Community Hospital in Gar-berville, all in California. Area radiologists donated reading services.
Limited to women at least 40 years of age, the raffle attracted 730 women in 2008, said Rose Gale-Zoeellick, executive director of the Humboldt Community Health Project in Arcata. Participation was free.
Each winner received a certificate for the mammography facility of her choice, as well as a gift bag. Insured winners were given the right to give their certificates to a friend or relative.
All participants received information from the community health project and cancer society advising about “Every Woman Counts” and “Family Planning Access, Care and Treatment,” two state programs that cover screening mammography for women over age 40.
The health project followed up directly with Spanish-speaking and Native American women to determine their health status, including the presence of palpable breast masses, and to refer them to health services for evaluation, Gale-Zoellick said.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.